Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2307-2026

Aligned Medical AMS16835 Fluids Kit RX Recall

Aligned Medical AMS16835 Fluids Kit RX

FDA recall Class II

Ongoing

FDA lists this Class II recall for Aligned Medical AMS16835 Fluids Kit RX. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2307-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 27, 2026
FDA report date
Jun 10, 2026
Quantity in commerce
875 kits
Distribution
See key details
FDA cause
Nonconforming Material/Component

What is being recalled?

Aligned Medical AMS16835 Fluids Kit RX

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

UDI-DI: B098AMS168350; Lot Numbers: 233828, 236048, 236359, 236662, 238580, 239934, 239935

View the original FDA recall notice

Why was this product recalled?

Lidocaine Hydrochloride Injection, USP, which was recalled by a supplier for quality issues, was included in custom convenience kits.

What actions did Windstone Medical Packaging, Inc. take?

An URGENT: MEDICAL DEVICE RECALL dated 4/27/26 was sent to customers. Please Note: Since AMS manufactured convenience kits that contain Huons Co. Ltd. Pharmacy Lidocaine HCL 1% 5ML SDV, we are extending our recall strategy to the end user level. AMS requests that you undertake the following activities: 1. Immediately check your inventory for the recalled products listed above and place them under quarantine. 2. Due to the manufacturing process any finished sterilized packs remaining in inventory, or at your facility will require over labeling for all products affected by this recall. Packs will be labeled with a sticker attached to each pack. This sticker will read: RECALL NOTICE Huons Co. Ltd. announced the recall of 73293-0001-2 Lidocaine Hydrochloride Injection contained in this kit after it was sealed and sterilized. All other components in the kit are not affected by this recall. " At the time the kit is opened for use any Huons Co. Ltd. Lidocaine Hydrochloride Injection should be identified, and quarantined. " The recalled Huons Co. Ltd. Lidocaine Hydrochloride Injection should be rendered unusable to protect against inadvertent use and returned to AMS. 3. Complete the attached Recall Reply Form listing all inventory of affected product by lot number and quantity. 4. If you have further distributed this product, please identify your distribution partners, and notify them at once of the product recall. Your notification to your customers should include a copy of this notification letter. 5. Please complete the Recall Reply Form within 5 business days and return via email to fieldcorrectiveaction@alignedmedical.com even if you have no affected product on hand. 6. Indicate on the Recall Reply Form if a replacement Huons Co. Ltd. product is needed. If you have any questions or concerns please do not hesitate to contact us at fieldcorrectiveaction@alignedmedicalsolutions.com. Dear Customer, This letter is to describe the process for placing the "Recall Notice

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology